← Every lobbying firm

W Strategies, LLC

A registered lobbying firm, and the clients it files for. Everything here comes from the quarterly disclosures it is required to make under the Lobbying Disclosure Act. Filed as W STRATEGIES, LLC.

Clients
11
named in its filings
Filings
23
2026
Fees reported
$1.1M
across every filing

Who it represents

Largest first, by what the filings report being paid.

ClientFees
Astrazeneca Pharmaceuticals LPAstraZeneca PLC$160K
Incyte CorporationIncyte Corp$120K
Gilead Sciences, Inc.Gilead Sciences, Inc$120K
Abbvie Inc.AbbVie Inc$100K
Merck & Co., Inc.Merck & Co Inc$100K
Otsuka America Pharmaceutical, Inc.Otsuka Holdings Co Ltd$100K
Sanofi U.S. Services, Inc.Sanofi SA$100K
Abbott Laboratories$100K
Bristol-Myers Squibb CompanyBristol-Myers Squibb Co$80K
Medtronic, Inc.Medtronic PLC$80K
Exelixis, Inc.Exelixis Inc$60K

Every filing

Newest first, and within a year the largest.

ClientFee
Astrazeneca Pharmaceuticals LP$80K
Astrazeneca Pharmaceuticals LP$80K
Incyte Corporation$60K
Gilead Sciences, Inc.$60K
Exelixis, Inc.$60K
Gilead Sciences, Inc.$60K
Incyte Corporation$60K
Abbvie Inc.$50K
Bristol-Myers Squibb Company$50K
Abbvie Inc.$50K
Merck & Co., Inc.$50K
Merck & Co., Inc.$50K
Otsuka America Pharmaceutical, Inc.$50K
Sanofi U.S. Services, Inc.$50K
Sanofi U.S. Services, Inc.$50K
Abbott Laboratories$50K
Abbott Laboratories$50K
Otsuka America Pharmaceutical, Inc.$50K
Medtronic, Inc.$40K
Medtronic, Inc.$40K
Bristol-Myers Squibb Company$30K
Bristol-Myers Squibb Company—
Exelixis, Inc.—

Source: quarterly LD-2 disclosures filed under the Lobbying Disclosure Act. A fee covers everything the firm did for that client in the period, so it cannot be attributed to any one issue on the list. A filing that states no figure contributes nothing rather than a zero. Clients with no ticker are kept: a trade association or a foreign ministry is as much a part of what the firm does as a listed company.

Related datasets